Vifor Pharma’s CHF 20 Million Acquisition of Inositec

Kellerhals Carrard advised Vifor Pharma on the transaction. Vischer advised Inositec on the deal. Vifor Pharma acquired the Swiss firm Inositec AG, a clinical stage biopharmaceutical company…

This content is for Standard 1 Year members only.
Login Join Now

Prysmian’s Acquisition of Encore Wire

OneMedNet’s Securities Purchase Agreement

Cameron International Corp. v. Nitro Fluids LLC

Eurofarma Laboratorios’ R$3 Billion Debentures Issuance

Inmuebles Panamericana’s S/110 Million Securitized Bonds Issuance

Drip-Plan’s Acquisition of Nordeste Irrigação

Q-Park’s Refinancing of its Revolving Credit Facility

PKO Bank Hipoteczny’s PLN 1 Billion Mortgage Covered Bonds Issuance

Swisscanto Anlagestiftung and PUBLICA’s Acquisition of La Maladière Stadium

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

Franklin Templeton’s Launch in Saudi Arabia

Savino Del Bene’s Acquisition of Stakes in Trans Okyanus and Bogazici Ekspres

National Finance Co. S.A.O.G.’s OMR25 Million Unsecured Bonds Issuance

Bloomberg’s Victory in the Supreme Court of India

Singapore Airlines’ Bonds Offering

Aliena’s Series A Investment Round

McDermott Supercharges International Tax Capabilities with Addition of Two Partners in Paris

Reed Smith expands global energy practice with leading LNG partner

Venable LLP adds three Product Liability/Mass Torts partners in Chicago and LA

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

McDermott Supercharges International Tax Capabilities with Addition of Two Partners in Paris

Reed Smith expands global energy practice with leading LNG partner

BMH BRÄUTIGAM becomes NEON

Vifor Pharma’s CHF 20 Million Acquisition of Inositec

Author: Federica Tiefenthaler